LGND: Ligand Pharmaceuticals Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Ligand Pharmaceuticals Inc (LGND).
$2.02B Market Cap.
LGND Market Cap. (MRY)
LGND Shares Outstanding (MRY)
LGND Assets (MRY)
Total Assets
$941.77M
Total Liabilities
$111.33M
Total Investments
$194.77M
LGND Income (MRY)
Revenue
$167.13M
Net Income
-$4.03M
Operating Expense
$178.66M
LGND Cash Flow (MRY)
CF Operations
$97.05M
CF Investing
-$143.66M
CF Financing
$97.14M
LGND Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $941,774,000 (19.63%) | $787,216,000 (3.22%) | $762,668,000 (-41.22%) | $1,297,590,000 (-4.75%) |
Assets Current | $331,559,000 (39.65%) | $237,429,000 (-9.93%) | $263,601,000 (-43.28%) | $464,751,000 (-7.15%) |
Assets Non-Current | $610,215,000 (10.99%) | $549,787,000 (10.16%) | $499,067,000 (-40.08%) | $832,839,000 (-3.35%) |
Goodwill & Intangible Assets | $371,898,000 (-7.71%) | $402,976,000 (-12.07%) | $458,310,000 (-6.94%) | $492,474,000 (-38.13%) |
Shareholders Equity | $830,439,000 (18.48%) | $700,913,000 (17.31%) | $597,485,000 (-27.24%) | $821,159,000 (15.73%) |
Property Plant & Equipment Net | $24,806,000 (-1.02%) | $25,062,000 (-8.84%) | $27,491,000 (-15.68%) | $32,602,000 (-12.28%) |
Cash & Equivalents | $72,307,000 (215.01%) | $22,954,000 (-49.00%) | $45,006,000 (130.54%) | $19,522,000 (-59.00%) |
Accumulated Other Comprehensive Income | -$5,942,000 (-627.29%) | -$817,000 (16.97%) | -$984,000 (-7.31%) | -$917,000 (-14.48%) |
Deferred Revenue | $3,524,000 (32.18%) | $2,666,000 (568.17%) | $399,000 (-38.99%) | $654,000 (-97.78%) |
Total Investments | $194,766,000 (-0.97%) | $196,676,000 (17.87%) | $166,864,000 (-48.11%) | $321,586,000 (-11.55%) |
Investments Current | $183,858,000 (24.77%) | $147,355,000 (0%) | $0 (0%) | $321,586,000 (-11.55%) |
Investments Non-Current | $10,908,000 (-77.88%) | $49,321,000 (1544.03%) | $3,000,000 (0%) | $0 (0%) |
Inventory | $14,114,000 (-41.12%) | $23,969,000 (80.30%) | $13,294,000 (-51.35%) | $27,326,000 (3.17%) |
Trade & Non-Trade Receivables | $38,376,000 (16.58%) | $32,917,000 (8.19%) | $30,424,000 (-64.40%) | $85,453,000 (50.32%) |
Trade & Non-Trade Payables | $5,233,000 (115.62%) | $2,427,000 (-54.27%) | $5,307,000 (-36.84%) | $8,403,000 (122.07%) |
Accumulated Retained Earnings (Deficit) | $498,984,000 (-0.80%) | $503,016,000 (11.57%) | $450,862,000 (0.39%) | $449,090,000 (14.58%) |
Tax Assets | $4,145,000 (-37.28%) | $6,609,000 (43.24%) | $4,614,000 (-88.99%) | $41,922,000 (57.98%) |
Tax Liabilities | $33,723,000 (6.64%) | $31,622,000 (3.29%) | $30,615,000 (-0.78%) | $30,856,000 (-52.23%) |
Total Debt | $7,105,000 (15.25%) | $6,165,000 (-92.97%) | $87,746,000 (-72.95%) | $324,386,000 (-28.93%) |
Debt Current | $1,290,000 (214.63%) | $410,000 (-99.47%) | $77,410,000 (5378.41%) | $1,413,000 (-83.33%) |
Debt Non-Current | $5,815,000 (1.04%) | $5,755,000 (-44.32%) | $10,336,000 (-96.80%) | $322,973,000 (-27.90%) |
Total Liabilities | $111,335,000 (29.00%) | $86,303,000 (-47.75%) | $165,183,000 (-65.33%) | $476,431,000 (-27.01%) |
Liabilities Current | $37,112,000 (121.14%) | $16,782,000 (-83.02%) | $98,810,000 (137.15%) | $41,665,000 (-58.38%) |
Liabilities Non-Current | $74,223,000 (6.76%) | $69,521,000 (4.74%) | $66,373,000 (-84.73%) | $434,766,000 (-21.33%) |
LGND Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $167,133,000 (27.28%) | $131,314,000 (-33.09%) | $196,245,000 (-18.75%) | $241,544,000 (47.68%) |
Cost of Revenue | $11,074,000 (5.35%) | $10,512,000 (-80.10%) | $52,827,000 (-15.04%) | $62,176,000 (104.40%) |
Selling General & Administrative Expense | $78,654,000 (48.99%) | $52,790,000 (-24.65%) | $70,062,000 (49.74%) | $46,790,000 (-22.03%) |
Research & Development Expense | $21,425,000 (-12.68%) | $24,537,000 (-32.00%) | $36,082,000 (12.39%) | $32,105,000 (-20.73%) |
Operating Expenses | $178,665,000 (64.12%) | $108,860,000 (-22.45%) | $140,381,000 (85.89%) | $75,517,000 (-21.04%) |
Interest Expense | $3,037,000 (362.96%) | $656,000 (-63.54%) | $1,799,000 (-90.83%) | $19,619,000 (-28.44%) |
Income Tax Expense | $6,550,000 (-33.44%) | $9,841,000 (-76.13%) | $41,230,000 (1093.97%) | -$4,148,000 (21.82%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $1,665,000 (-94.08%) | $28,142,000 (46.46%) | $19,215,000 (100.51%) |
Consolidated Income | -$4,032,000 (-107.73%) | $52,154,000 (256.33%) | -$33,361,000 (-158.39%) | $57,138,000 (2014.17%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | -$4,032,000 (-107.73%) | $52,154,000 (256.33%) | -$33,361,000 (-158.39%) | $57,138,000 (2014.17%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$4,032,000 (-107.73%) | $52,154,000 (256.33%) | -$33,361,000 (-158.39%) | $57,138,000 (2014.17%) |
Weighted Average Shares | $18,290,000 (5.73%) | $17,298,000 (2.55%) | $16,868,000 (1.43%) | $16,630,000 (2.75%) |
Weighted Average Shares Diluted | $18,290,000 (3.00%) | $17,757,000 (5.27%) | $16,868,000 (-2.19%) | $17,246,000 (2.50%) |
Earning Before Interest & Taxes (EBIT) | $5,555,000 (-91.13%) | $62,651,000 (548.02%) | $9,668,000 (-86.68%) | $72,609,000 (279.67%) |
Gross Profit | $156,059,000 (29.19%) | $120,802,000 (-15.77%) | $143,418,000 (-20.04%) | $179,368,000 (34.72%) |
Operating Income | -$22,606,000 (-289.30%) | $11,942,000 (293.22%) | $3,037,000 (-97.08%) | $103,851,000 (176.94%) |
LGND Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | -$143,664,000 (-1129.79%) | -$11,682,000 (-107.14%) | $163,624,000 (436.07%) | $30,523,000 (-86.82%) |
Net Cash Flow from Financing | $97,141,000 (262.04%) | -$59,947,000 (78.28%) | -$275,990,000 (-133.37%) | -$118,265,000 (61.92%) |
Net Cash Flow from Operations | $97,047,000 (95.75%) | $49,577,000 (-64.04%) | $137,850,000 (74.94%) | $78,798,000 (44.36%) |
Net Cash Flow / Change in Cash & Cash Equivalents | $49,353,000 (323.80%) | -$22,052,000 (-186.53%) | $25,484,000 (0%) | $0 (0%) |
Net Cash Flow - Business Acquisitions and Disposals | -$185,386,000 (-143.99%) | -$75,982,000 (-10030.93%) | -$750,000 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | $43,543,000 (-35.80%) | $67,821,000 (-62.99%) | $183,257,000 (358.03%) | $40,010,000 (-93.50%) |
Capital Expenditure | -$1,821,000 (48.28%) | -$3,521,000 (80.35%) | -$17,923,000 (-116.80%) | -$8,267,000 (-166.68%) |
Issuance (Repayment) of Debt Securities | -$451,000 (99.42%) | -$77,848,000 (70.15%) | -$260,801,000 (-78.62%) | -$146,010,000 (37.00%) |
Issuance (Purchase) of Equity Shares | $65,588,000 (192.18%) | $22,448,000 (594.55%) | $3,232,000 (-90.43%) | $33,763,000 (145.03%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | -$1,171,000 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Share Based Compensation | $41,089,000 (59.61%) | $25,743,000 (-57.30%) | $60,285,000 (55.44%) | $38,783,000 (26.22%) |
Depreciation Amortization & Accretion | $37,365,000 (-2.33%) | $38,256,000 (-32.95%) | $57,055,000 (2.27%) | $55,786,000 (88.63%) |
LGND Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | 93.40% (1.52%) | 92.00% (25.85%) | 73.10% (-1.62%) | 74.30% (-8.72%) |
Profit Margin | -2.40% (-106.05%) | 39.70% (333.53%) | -17.00% (-171.73%) | 23.70% (1416.67%) |
EBITDA Margin | 25.70% (-66.54%) | 76.80% (125.88%) | 34.00% (-36.09%) | 53.20% (78.52%) |
Return on Average Equity (ROAE) | -0.50% (-106.41%) | 7.80% (277.27%) | -4.40% (-161.11%) | 7.20% (1900.00%) |
Return on Average Assets (ROAA) | -0.40% (-105.97%) | 6.70% (303.03%) | -3.30% (-173.33%) | 4.50% (2350.00%) |
Return on Sales (ROS) | 3.30% (-93.08%) | 47.70% (873.47%) | 4.90% (-83.72%) | 30.10% (157.26%) |
Return on Invested Capital (ROIC) | 1.20% (-94.26%) | 20.90% (646.43%) | 2.80% (-67.82%) | 8.70% (383.33%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% (0%) |
Price to Earnings Ratio (P/E) | -487.05 (-2159.47%) | 23.65 (170.10%) | -33.74 (-175.14%) | 44.9 (108.13%) |
Price to Sales Ratio (P/S) | 11.73 (24.64%) | 9.41 (63.85%) | 5.74 (-46.00%) | 10.63 (8.06%) |
Price to Book Ratio (P/B) | 2.44 (37.20%) | 1.78 (-5.93%) | 1.89 (-39.90%) | 3.14 (39.38%) |
Debt to Equity Ratio (D/E) | 0.13 (8.94%) | 0.12 (-55.43%) | 0.28 (-52.41%) | 0.58 (-36.96%) |
Earnings Per Share (EPS) | -0.22 (-107.28%) | 3.02 (252.53%) | -1.98 (-157.56%) | 3.44 (2011.11%) |
Sales Per Share (SPS) | 9.14 (20.38%) | 7.59 (-34.75%) | 11.63 (-19.90%) | 14.53 (43.73%) |
Free Cash Flow Per Share (FCFPS) | 5.21 (95.49%) | 2.66 (-62.55%) | 7.11 (67.65%) | 4.24 (33.32%) |
Book Value Per Share (BVPS) | 45.4 (12.05%) | 40.52 (14.40%) | 35.42 (-28.27%) | 49.38 (12.64%) |
Tangible Assets Book Value Per Share (TABVPS) | 31.16 (40.27%) | 22.21 (23.10%) | 18.04 (-62.73%) | 48.41 (38.36%) |
Enterprise Value Over EBIT (EV/EBIT) | 354 (1670.00%) | 20 (-84.38%) | 128 (220.00%) | 40 (-52.38%) |
Enterprise Value Over EBITDA (EV/EBITDA) | 45.86 (275.52%) | 12.21 (-34.19%) | 18.56 (-17.51%) | 22.5 (-31.63%) |
Asset Turnover | 0.18 (8.33%) | 0.17 (-14.72%) | 0.2 (4.23%) | 0.19 (45.38%) |
Current Ratio | 8.93 (-36.85%) | 14.15 (430.28%) | 2.67 (-76.08%) | 11.15 (123.08%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | $95,226,000 (106.76%) | $46,056,000 (-61.60%) | $119,927,000 (70.03%) | $70,531,000 (36.99%) |
Enterprise Value (EV) | $1,968,377,217 (59.73%) | $1,232,330,120 (-0.48%) | $1,238,261,077 (-57.13%) | $2,888,432,069 (80.27%) |
Earnings Before Tax (EBT) | $2,518,000 (-95.94%) | $61,995,000 (687.84%) | $7,869,000 (-85.15%) | $52,990,000 (739.13%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | $42,920,000 (-57.47%) | $100,907,000 (51.23%) | $66,723,000 (-48.03%) | $128,395,000 (163.65%) |
Invested Capital | $467,562,000 (33.33%) | $350,669,000 (41.23%) | $248,288,000 (-76.76%) | $1,068,315,000 (22.09%) |
Working Capital | $294,447,000 (33.45%) | $220,647,000 (33.90%) | $164,791,000 (-61.05%) | $423,086,000 (5.65%) |
Tangible Asset Value | $569,876,000 (48.31%) | $384,240,000 (26.25%) | $304,358,000 (-62.20%) | $805,116,000 (42.17%) |
Market Capitalization | $2,024,639,217 (62.59%) | $1,245,276,120 (10.35%) | $1,128,491,077 (-56.28%) | $2,581,280,069 (61.30%) |
Average Equity | $813,334,000 (21.39%) | $670,004,500 (-10.94%) | $752,335,000 (-4.94%) | $791,395,500 (14.52%) |
Average Assets | $919,228,500 (17.64%) | $781,405,750 (-21.76%) | $998,686,250 (-22.02%) | $1,280,662,500 (1.67%) |
Invested Capital Average | $466,398,250 (55.70%) | $299,548,000 (-14.70%) | $351,177,000 (-57.81%) | $832,352,500 (-20.02%) |
Shares | 18,895,373 (8.37%) | 17,435,958 (3.21%) | 16,893,579 (1.09%) | 16,711,641 (3.86%) |
